## Core Concept
The World Health Organization (WHO) has guidelines for the treatment of leprosy, which is caused by *Mycobacterium leprae*. Leprosy is categorized into paucibacillary and multibacillary types based on the bacterial load and the number of skin lesions. Multibacillary leprosy is characterized by a higher bacterial load and typically presents with more than 5 skin lesions.

## Why the Correct Answer is Right
The WHO recommends a multidrug therapy (MDT) regimen for the treatment of leprosy. For multibacillary leprosy, the MDT regimen consists of rifampicin, dapsone, and clofazimine. According to the WHO guidelines, the duration of treatment for multibacillary leprosy is 12 months. This prolonged treatment duration is necessary to effectively reduce the bacterial load and prevent resistance.

## Why Each Wrong Option is Incorrect
* **Option A:** 6 months - This is the recommended duration for paucibacillary leprosy, not multibacillary leprosy.
* **Option B:** 2 months - This is too short for the treatment of multibacillary leprosy and does not align with WHO guidelines.
* **Option D:** 18 months - While ensuring adequate treatment is crucial, the WHO specifically recommends 12 months for multibacillary leprosy, making 18 months longer than necessary.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the treatment duration for multibacillary leprosy according to WHO is 12 months, which includes rifampicin 600 mg/month, dapsone 100 mg/day, and clofazimine 300 mg/month for 12 months. Monitoring for side effects and ensuring completion of the full treatment course are critical for cure and prevention of drug resistance.

**Correct Answer: C. 12 months**